Rohini Chavare: PGT Technology Enhancements Driving IVF Success Rates
Rohini Chavare, Assistant Manager at Marketsand Markets, shared a post on LinkedIn:
“Preimplantation Genetic Testing (PGT): Advancing Precision in IVF Embryo Selection
Download PDF Brochure.
Preimplantation Genetic Testing (PGT) is transforming assisted reproduction by enabling early detection of genetic abnormalities before embryo implantation. By combining advanced technologies like NGS, PCR, SNP analysis, and Array CGH, PGT helps improve IVF success rates and supports informed reproductive decisions.
As genetic screening technologies continue to evolve, PGT is playing a critical role in reducing inherited disease risk and improving patient outcomes in reproductive medicine.
The preimplantation genetic testing market is projected to reach USD 1,135.0 million by 2030 from USD 690.2 million in 2025, at a CAGR of 10.5% from 2025 to 2030.
The procedure type segment comprises preimplantation genetic screening and preimplantation genetic diagnosis. Preimplantation genetic screening is highly demanded with the rising demand for assisted reproductive technologies.
Key technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS), and fluorescence in situ hybridization (FISH). NGS dominates the market with increasing use of these systems in fertility clinics and research institutes for preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD).
Major market players have adopted organic and inorganic strategies, including product launches, partnerships, and investments. For instance, in July 2023, Thermo Fisher Scientific Inc. (US) launched two new NGS-based test kits to support preimplantation genetic testing for aneuploidy (PGT-A), commonly used in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) research.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 28, 2026, 15:55Katy Encalade: What Are the Biggest Myths About Egg Donation?
-
Oct 28, 2026, 15:53Diana Kayal: A Free Webinar on Trauma, Infertility and the Patient Journey
-
Oct 28, 2026, 15:49Rebecca Watson O’Connor: Applications for the 2027 PRIMED Cohort Are Open
-
Oct 28, 2026, 15:45Martin Varsavsky: Gameto Has Been Acquired by Ferring for 1.38 Billion Dollars
-
Oct 28, 2026, 15:37Gili Band: The People Are What Stay With Me After Day 1 at ASRM 2026
-
Oct 28, 2026, 13:56Samantha Payne: NSW Releases Final Report on Fertility Support and Assisted Reproductive Treatment
-
Oct 28, 2026, 13:53True Friendship and PCOS: Why Emotional Support Matters – PCOS Millennials
-
Oct 28, 2026, 13:51Fred Ushakov: The Future of Prenatal Screening, The Future of Your Practice
-
Oct 28, 2026, 13:49Hosting the First-Ever Fairfax Awards – Fairfax EggBank
